Literature DB >> 3712389

Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state.

J Köbberling, M G Dunnigan.   

Abstract

Familial lipodystrophy (referred to in publications as the Köbberling-Dunnigan syndrome) comprises at least two clinical phenotypes which are consistent within each pedigree. In type 1 familial lipodystrophy, loss of subcutaneous fat is confined to the limbs, sparing the face and trunk. In type 2 familial lipodystrophy, the trunk is also affected with the exception of the vulva, giving an appearance of labial hypertrophy. Diabetes mellitus, hyperlipoproteinaemia, and acanthosis nigricans are present to a variable degree in some but not all patients with familial lipodystrophy, and the abnormal distribution of subcutaneous fat is the essential hallmark of the syndrome. In addition to a survey of published reports, new cases with the syndrome are described. Both types of partial lipodystrophy, occurring either as familial disease or as sporadic cases, have only been observed in female patients. Study of the pedigrees of five families with familial lipodystrophy (two Scottish and three German) suggests an X linked dominant mode of transmission, lethal in the hemizygous (XY) state. The two clinical phenotypes with their variably expressive metabolic abnormalities are consistent either with different mutants of the same allele or with two genes on adjacent loci. Other clinical phenotypes of familial lipodystrophy may exist due to further mutations of the same allele or of genes on adjacent loci. The nature of the disorder in patients with familial lipodystrophy usually escapes recognition for many years and the syndrome is almost certainly much commoner than the few families described to date suggest.

Entities:  

Mesh:

Year:  1986        PMID: 3712389      PMCID: PMC1049565          DOI: 10.1136/jmg.23.2.120

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities.

Authors:  M B Davidson; R T Young
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

2.  Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome?

Authors:  M SEIP
Journal:  Acta Paediatr       Date:  1959-11       Impact factor: 2.299

3.  An undiagnosed endocrinometabolic syndrome: report of 2 cases.

Authors:  W BERARDINELLI
Journal:  J Clin Endocrinol Metab       Date:  1954-02       Impact factor: 5.958

4.  Lipodystrophy of limbs associated with insulin resistance.

Authors:  D Lillystone; R J West
Journal:  Arch Dis Child       Date:  1975-09       Impact factor: 3.791

5.  Lipodystrophy with hyperlipidaemia: the role of insulin in very low density lipoprotein over-synthesis.

Authors:  A Chait; E Janus; A S Mason; B Lewis
Journal:  Clin Endocrinol (Oxf)       Date:  1979-02       Impact factor: 3.478

6.  Familial lipoatrophic diabetes with dominant transmission. A new syndrome.

Authors:  M G Dunnigan; M A Cochrane; A Kelly; J W Scott
Journal:  Q J Med       Date:  1974-01

7.  Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes.

Authors:  J Köbberling; B Willms; R Kattermann; W Creutzfeldt
Journal:  Humangenetik       Date:  1975-09-10

8.  The effect of fenfluramine and caloric restriction on carbohydrate homeostasis in patients with lipodystrophy.

Authors:  T A Wilson; T Melton; W L Clarke
Journal:  Diabetes Care       Date:  1983 Mar-Apr       Impact factor: 19.112

9.  Heterogeneity of the insulin-receptor interaction in lipoatropic diabetes.

Authors:  H Wachslicht-Rodbard; M Muggeo; C R Kahn; G A Saviolakis; L C Harrison; J S Flier
Journal:  J Clin Endocrinol Metab       Date:  1981-03       Impact factor: 5.958

  9 in total
  23 in total

Review 1.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

Review 2.  Lipodystrophy syndromes.

Authors:  Pedro Herranz; Raul de Lucas; Luis Pérez-España; Matias Mayor
Journal:  Dermatol Clin       Date:  2008-10       Impact factor: 3.478

3.  A defect in the regional deposition of adipose tissue (partial lipodystrophy) is encoded by a gene at chromosome 1q.

Authors:  S N Jackson; J Pinkney; A Bargiotta; C D Veal; T A Howlett; P G McNally; R Corral; A Johnson; R C Trembath
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

Review 4.  Assembling the adipose organ: adipocyte lineage segregation and adipogenesis in vivo.

Authors:  Zachary L Sebo; Matthew S Rodeheffer
Journal:  Development       Date:  2019-04-04       Impact factor: 6.868

Review 5.  Diseases of the Nucleoskeleton.

Authors:  James M Holaska
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

Review 6.  Genetics of Lipodystrophy.

Authors:  Marissa Lightbourne; Rebecca J Brown
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-22       Impact factor: 4.741

7.  "Fat Shadows" From DXA for the Qualitative Assessment of Lipodystrophy: When a Picture Is Worth a Thousand Numbers.

Authors:  Rasimcan Meral; Benjamin J Ryan; Noemi Malandrino; Abdelwahab Jalal; Adam H Neidert; Ranganath Muniyappa; Barış Akıncı; Jeffrey F Horowitz; Rebecca J Brown; Elif A Oral
Journal:  Diabetes Care       Date:  2018-10       Impact factor: 19.112

8.  Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.

Authors:  Cristina Guillín-Amarelle; Sofía Sánchez-Iglesias; Ana Castro-Pais; Leticia Rodriguez-Cañete; Lucía Ordóñez-Mayán; Marcos Pazos; Blanca González-Méndez; Silvia Rodríguez-García; Felipe F Casanueva; Ana Fernández-Marmiesse; David Araújo-Vilar
Journal:  Endocrine       Date:  2016-07-30       Impact factor: 3.633

Review 9.  Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome.

Authors:  C Ronald Kahn; Guoxiao Wang; Kevin Y Lee
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

10.  Magnetic resonance spectroscopy to assess hepatic steatosis in patients with lipodystrophy.

Authors:  Canan Altay; Mustafa Seçil; Süleyman Cem Adıyaman; Başak Özgen Saydam; Tevfik Demir; Gülçin Akıncı; Ilgın Yıldırım Simsir; Erdal Eren; Ela Temeloğlu Keskin; Leyla Demir; Hüseyin Onay; Haluk Topaloğlu; Banu Sarer Yürekli; Nilüfer Özdemir Kutbay; Ramazan Gen; Barış Akıncı
Journal:  Turk J Gastroenterol       Date:  2020-08       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.